Aflibercept Injection

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

The Sahlgrenska Anti-VEGF Study

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated with Proton Therapy for a Large Choroidal Melanoma

Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial

Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT)

Adjunct Episcleral Brachytherapy for PCV

Treat-and-extend Using Aflibercept for Type 3 Neovascularization

Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer

Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement

Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye

Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid

Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema

Intense Treatment Regimen With Intravitreal Aflibercept Injection

Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema

Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization